This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Ars Pharmaceutical Operations, Inc. The $1,025,000.00 contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from September 15, 2024 to March 14, 2025 and was set up as a multiple award vehicle with no set-asides. As an FSS contract, the awarded prime contractor...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Viiv Healthcare Company, a foreign-owned for-profit manufacturer. The contract, valued at a ceiling of $1,870,730,000.00, is for the delivery of pharmaceutical and hematology-related products under FSS Schedule 65 IB. The contract has a period of performance from August 15, 2021, to August 14, 2026. This is a multiple-award contract, with no set-aside...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. federal government. The contract, valued at a ceiling of $25,000.00, is an interim agreement under FSS Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor for this multiple-award contract is Bridgebio Pharma, Inc., a for-profit organization. The period of performance runs from the award date of...
This Federal Supply Schedule (FSS) contract is an interim agreement under FSS Schedule 65 IB, which covers Drugs, Pharmaceuticals, & Hematology Related Products. The contract was awarded to Tilde Sciences LLC, a for-profit organization, by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency. The contract has a ceiling value of $25,000.00 and a period of performance from the award date of September 1, 2024 through February 28, 2025. It was awarded without any...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract, valued at a ceiling of $300,000.00, was awarded to Yaral Pharma Inc., a for-profit manufacturer, for a period of performance ending on April 30, 2028. The contract falls under Schedule 65 I B, "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS", and is intended to provide the agency...
The Federal Supply Schedule (FSS) contract 36F79724D037E was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Day One Biopharmaceuticals, Inc. on June 3, 2024. The contract is a multiple award under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products, with a ceiling value of $25,000.00 and a period of performance through November 30, 2024. The purpose of this FSS contract is to provide the VISN 12 agency with interim...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Saptalis Pharmaceuticals, LLC, a for-profit limited liability company. The contract is a multiple-award vehicle under FSS Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products, with a period of performance ending on March 31, 2025 and a ceiling value of $25,000.00. The contract aims to procure a range of pharmaceutical and...
This is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Bioxcel Therapeutics, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through February 14, 2023. The contract is for an "Interim Agreement under FSS Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products." This indicates the contract provides for the delivery of pharmaceutical and related...